FTC-L’Oreal Settlement Will Fuel Cosmetics Class Actions – Attorney
This article was originally published in The Rose Sheet
Class actions against cosmetics firms show no sign of slowing down, and FTC’s pending settlement with L’Oreal for gene-related anti-aging claims likely will spur further litigation in the sector, Edwards Wildman Palmer partner Ronie Schmelz says.
You may also be interested in...
Plant stem cell actives such as Mibelle Biochemistry's PhytoCellTec Malus Domestica were marquee ingredients for skin-care brands in the flourishing US anti-aging market years back. But what once was fruitful has turned rotten with regulatory crackdowns in recent years and class actions that continue to weigh on product manufacturers.
The recent action against L’Oreal sends a signal to industry that FTC is paying attention to their claims. In an interview with “The Rose Sheet,” attorneys from Edwards Wildman Palmer discuss the case’s implications and whether it heralds a new FTC focus on cosmetics.
The International Fragrance Association has given its ingredient safety standards a major overhaul based on a new methodology that accounts for aggregate exposure and an updated Quantitative Risk Assessment model for dermal sensitization.